|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/6883 |
| (11) | Number of the document | 2723865 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12802770.3 |
| Date of filing the European patent application | 2012-06-21 | |
| (97) | Date of publication of the European application | 2014-04-30 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/043584 |
| Date | 2012-06-21 |
| (87) | Number | WO 2012/177906 |
| Date | 2012-12-27 |
| (30) | Number | Date | Country code |
| 201161499664 P | 2011-06-21 | US | |
| 201161507093 P | 2011-07-12 | US | |
| 201161530112 P | 2011-09-01 | US | |
| 201161533737 P | 2011-09-12 | US |
| (72) |
SAH, Dinah, US
BUMCROT, David, US
SEHGAL, Alfica, US
|
| (73) |
Alnylam Pharmaceuticals, Inc.,
300 Third Street, Cambridge, MA 02142,
US
|
| (54) | METHODS FOR DETERMINING ACTIVITY OF RNAi IN A SUBJECT |
| METHODS FOR DETERMINING ACTIVITY OF RNAi IN A SUBJECT |